Startup co-founder uses diversity in research to cut drug development time and cost

Hear her story November 17 [] Having trouble viewing this email? [View it as a Web page](. USPTO Alert [US Patent and Trademark Office] Invest in HER: Empowering women's ventures [Women Entrepreneurs Graphic] Scientists can better predict how patients fighting obesity, diabetes, and cancer will respond to drug compounds, thanks to technology developed by a woman inspired to help her hometown of New Orleans. Biomedical engineer Dr. Trivia Frazier, co-founder of startup company Obatala Sciences, hopes her work to reduce drug development time and cost inspires budding scientists and future entrepreneurs. Hear more about Dr. Frazier's journey and learn about entrepreneur resources available to you at our upcoming [Women's Entrepreneurship (WE) event](, happening online or in person at the WB Collective in New Orleans this Friday, November 17 from 11 a.m. to 1 p.m. CT. Confirmed speakers: - Valencia Martin Wallace, Deputy Commissioner for Patents, U.S. Patent and Trademark Office (USPTO) - Dr. Trivia Frazier, President and CEO, Obatala Sciences - Khristie Dyson Landrew, Founder and CEO, Utopia Creations, LLC - Phala K. Mire, President and CEO, Women's Business Enterprise Council South (WBEC South) [Register today]( For more information, or if you have any questions, please email us at we@uspto.gov. To learn more about resources that support women entrepreneurs, please visit the [Empowering Women's Entrepreneurship webpage](. See upcoming events, mentorship opportunities, and tools available through the USPTO. [facebook](​[twitter](​[youtube](​[linkedin]( Stay connected with the USPTO by subscribing to regular email updates. Visit our subscription center at [www.uspto.gov/subscribe]( to update or change your email preferences. This email was sent from an unmonitored mailbox. To contact us, please visit our website [www.uspto.gov/about/contacts](. To ensure that you continue to receive our news and notices, please modify your email filters to allow mail from subscriptioncenter@subscriptions.uspto.gov. --------------------------------------------------------------- This email was sent to {EMAIL} using GovDelivery Communications Cloud on behalf of: United States Patent and Trademark Office ·600 Dulany Street · Alexandria , VA 22314 [GovDelivery logo](